Journal of Medical Virology

Papers
(The H4-Index of Journal of Medical Virology is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Comparison of the pediatric hospitalizations due to COVID‐19 and H1N1pdm09 virus infections during the pandemic period700
Diversity of picornaviruses detected in diarrheal samples from children in Belém, Brazilian Amazon (1982–2019)476
The potential rationale of COVID‐19 vaccine‐induced myopericarditis457
Comparative analyses of small molecule and antibody inhibition on glycoprotein‐mediated entry of Měnglà virus with other filoviruses405
Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic254
Association between cytomegalovirus seropositivity and all‐cause mortality: An original cohort study244
Molecular epidemiology of SARS‐CoV‐2 variants in circulation in the state of Maranhão, Brazil218
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries201
Circulating rotavirus P[8]‐lineage IV, unlike P[8]‐lineage III, significantly related to nonsecretors status in Iranian children201
Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China192
On coming back, the scaring COVID‐19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS‐CoV2 spreading177
Novel diarylpyrimidine subtypes as HIV‐1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile173
Comment on “The risk assessment of uveitis after COVID‐19 diagnosis”164
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond155
147
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID‐19 patients129
Previous SARS‐CoV‐2 infection is linked to lower vaccination intentions126
Significant neutralizing escapes of Omicron and its sublineages in SARS‐CoV‐2‐infected individuals vaccinated with inactivated vaccines125
Better detection of Torque teno virus in children with leukemia by metagenomic sequencing than by quantitative PCR117
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection116
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults113
Effects of baloxavir and oseltamivir antiviral therapy on the transmission of seasonal influenza in China: A mathematical modeling analysis111
Dynamics of spreading of SARS‐CoV‐2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains108
Effect of the coronavirus pandemic on tumor markers107
Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients106
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples104
BK Polyomavirus DNAemia With a High DNA Load Is Associated With De Novo Donor‐Specific HLA Antibodies in Kidney Transplant Recipients103
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico97
Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT‐PCR for SARS‐CoV‐292
Prisoners of variants, or free to act as prisoners of swabs? The case of Italy92
Prolonged fecal shedding of SARS‐CoV‐2 in a young immunocompetent COVID‐19 patient: A case report and literature overview91
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort88
No signs of “tripledemic” in Finnish children87
Issue Information85
84
Issue Information82
Comment on “A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination”81
COVID‐19 and Oncofertility: No SARS‐CoV‐2 in Semen but Inflammation Seems to Affect Sperm Parameters81
Corrigendum80
Risks of catching COVID‐19 according to vaccination status of healthcare workers during the SARS‐CoV‐2 Delta variant dominant period and their clinical characteristics77
Erratum76
Exploring the dynamics of the 2022 mpox outbreak in Canada76
Rotavirus trends and distribution of genotypes before and during COVID‐19 pandemic era: Bangladesh, 2017–202175
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India73
Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain72
ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function72
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity70
Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study68
Correction to “Fullerene (C60 & C70)‐Meso‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C”68
Ramsay Hunt syndrome and concurrent varicella‐zoster virus meningitis in Denmark: A nationwide cohort study67
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐1966
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 266
Identification of a new polyomavirus in distinct human populations and tissues66
Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study66
Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor65
Comparison of demographic and clinical characteristics of hospitalized COVID‐19 patients with severe/critical illness in the first wave versus the second wave64
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV63
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial63
A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity62
Issue Information61
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting61
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma61
Zoonotic spillover and extreme weather events drive the global outbreaks of airborne viral emerging infectious diseases61
Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer61
TLR3 polymorphisms are associated with the severity of hand, foot, and mouth disease caused by enterovirus A71 in a Chinese children population61
0.30475687980652